Quanterix (QTRX) Expands in Alzheimer's Testing With Alliances [Yahoo! Finance]
Quanterix Corporation (QTRX)
US:NASDAQ Investor Relations:
ir.quanterix.com/investor-relations
Company Research
Source: Yahoo! Finance
By partnering with AdventHealth, Mass General Brigham, Mayo Clinic, SC-ADRC and UPMC, Quanterix is set to enhance AD testing accessibility, thereby impacting millions of patients across 18 states. The financial terms of the collaborations have not been revealed. More on the News The collaborations will cover more than 140 hospitals across 18 states, serving approximately 21 million patients. This will mark a substantial expansion in clinical access to Quanterix's cutting-edge blood biomarker assays for AD. This expanded access promises to bridge the gap between traditional diagnostic methods and the pressing need for accurate, non-invasive AD testing. Transforming Diagnosis Landscape Traditionally, AD diagnosis relies on invasive procedures and costly biomarker detection methods, leaving a significant portion of patients undiagnosed or misdiagnosed.This inaccessibility has left 50-70% of symptomatic AD patients without a correct and timely diagnosis, impacting the quality of
Show less
Read more
Impact Snapshot
Event Time:
QTRX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
QTRX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
QTRX alerts
High impacting Quanterix Corporation news events
Weekly update
A roundup of the hottest topics
QTRX
News
- Quanterix To Report First Quarter 2024 Financial Results [Yahoo! Finance]Yahoo! Finance
- Quanterix To Report First Quarter 2024 Financial ResultsBusiness Wire
- Quanterix Co. (NASDAQ: QTRX) had its price target lowered by analysts at Canaccord Genuity Group Inc. from $32.00 to $25.00. They now have a "buy" rating on the stock.MarketBeat
- Investing in Quanterix (NASDAQ:QTRX) a year ago would have delivered you a 111% gain [Yahoo! Finance]Yahoo! Finance
- Quanterix Outlines Partner Path With Labs to Expedite Building Global Alzheimer's Disease Testing Infrastructure [Yahoo! Finance]Yahoo! Finance
QTRX
Earnings
- 2/29/24 - Miss
QTRX
Sec Filings
- 4/17/24 - Form 4
- 4/15/24 - Form ARS
- 4/15/24 - Form DEF
- QTRX's page on the SEC website